Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins

Genes to Cells

Volumn 13, Issue 10, 2008, Pages 1061-1073

  Kohno, Tomoko ^a   Daa, Tsutomu ^b   Otani, Hiroshi ^c   Shimokawa, Isao ^c   Yokoyama, Shigeo ^b   Matsuyama, Toshifumi ^a  

^a Department of Molecular Microbiology and Immunology   (Japan)

^b OITA UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TNFSF13B PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL STRAIN COS1; CERCOPITHECUS; CYTOPLASM; GENETICS; HELA CELL; HUMAN; METABOLISM; OSTEOSARCOMA; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; HELA CELLS; HUMANS; NF-KAPPA B; OSTEOSARCOMA; SIGNAL TRANSDUCTION;

EID: 58149163380     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2008.01227.x     Document Type: Article

References (39)

1. Barton, E.S., Forrest, J.C., Connolly, J.L., Chappell, J.D., Liu, Y., Schnell, F.J., Nusrat, A., Parkos, C.A. & Dermody, T.S. (2001) Junction adhesion molecule is receptor for reovirus. Cell 104, 441-451.
2. Beg, A.A. & Baltimore, D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
3. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G. & Siebenlist, U. (1995) Control of IκBα proteolysis by site specific, signal-induced phosphorylation. Science 267, 1485-1488.
4. von Bülow, G.U. & Bram, R.J. (1997) NF-AT activation induced by a CAML-interacting member of the Tumor necrosis factor receptor superfamily. Science 278, 138-141.
5. Castigli, E., Wilson, S.A., Scott, S., Dedeoglu, F., Xu, S., Lam, K.P., Bram, R.J., Jabara, H. & Geha R.S. (2005) TACI and BAFF-R mediate isotype switching in B cell. J. Exp. Med. 201, 35-39.
6. Chen, Z., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D., Ballard, D. & Maniatis, T. (1995) Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9, 1586-1597.
7. Claudio, E., Brown, K., Park, S., Wang, H. & Siebenlist, U. (2002) BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat Immunol. 3, 958-965.
8. Craxton, A., Magaletti, D., Ryan, E.J. & Clark, E.A. (2003) Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101, 4464-4471.
9. Daridon, C., Devauchelle, V., Hutin, P., Le Berre, R., Martins-Carvalho, C., Bendaoud, B., Dueymes, M., Saraux, A., Youinou, P. & Pers, J.O. (2007) Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 56, 1134-1144.
10. Darnell, J.E., Kerr, I.M. & Stark, G.R. (1994) JAK-STAT path-ways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1420.
11. Gerber, H.P., Malik, A.K., Solar, G.P., Sherman, D., Liang, X.H., Meng, G., Hong, K., Marsters, J.C. & Ferrara, N. (2002) VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417, 954-958.
12. Hanahan, D. & Weinberg, R.A. (2000) The Hallmarks of Cancer. Cell 100, 57-70.
13. Hatzoglou, A., Roussel, J., Bourgeade, M.F., Rogier, E., Madry, C., Inoue, J., Devergne, O. & Tsapis, A. (2000) TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF)1, TRAF2, and TRAF3 and activates NF-κB, Elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165, 1322-1330.
14. Hironaka, N., Mochida, K., Mori, N., Maeda, M., Yamamoto, N. & Yamaoka, S. (2004) Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia 6, 266-278.
15. Hirt, B. (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369.
16. Hsu, B.L., Harless, S.M., Lindsley, R.C., Hilbert, D. & Cancro, M.P. (2002) BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol. 168, 5993-5996.
17. Huard, B., Arlettaz, L., Ambrose, C., Kindler, V., Mauri, D., Roosnek, E., Tschopp, J., Schneider, P. & French, L.E. (2004) BAFF production by antigen-presenting cells provides T cell co-stimulation. Int. Immunol. 16, 467-475.
18. Inoue, Y., Tsushima, H., Ando, K., Sawayama, Y., Sakai, M., Yamasaki, R., Matsuo, E., Tsutsumi, C., Imaizumi, Y., Iwanaga, M., Imanishi, D., Taguchi, J., Miyazaki, Y. & Tomonaga, M. (2006) Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3α/CCL20 is induced by inflammatory cytokines. Exp. Hematol. 34, 19-26.
19. Kalled, S.L. (2006) Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Seminars Immunol. 18, 290-296.
20. Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W., French D.M., Grewal, I.S., Cochran, A.G., Gordon, N.C., Yin, J.P., Starovasnik, M.A. & Dixit, V.M. (2002) BAFF/BLyS receptor 3 binds the B cell survival factor BAFF through a discrete surface loop and promotes processing of NF-κB2. Immunity 10, 515-524.
21. Laabi, Y., Gras, M.P., Brouet, J.C., Berger, R., Larsen, C.J. & Tsapis, A. (1994) The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res. 22, 1147-1154.
22. MacKay, F., Schneider, P., Rennert, P. & Browning, J. (2003) BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21, 231-264.
23. Munk Pedersen, I. & Reed, J. (2004) Microenvironmental interactions and survival of CLL B-cells. Leuk. Lymphoma 45, 2365-2372.
24. Ogura, M., Shibata, T., Yi, J., Liu, J., Qu, R., Harada, H. & Hiraoka, M. (2005) A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas. Cancer Science 96, 288-294.
25. 3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J. Cell Biochem. 95, 955-969.
26. Pellegrini, S., John, J., Shearer, M., Kerr, I.M. & Stark, G.R. (1989) Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605-4612.
27. Regnier, C.H., Song, H.Y., Gao, X., Goeddel, D.V., Cao, Z. & Rothe, M. (1997) Identification and characterization of an IκB. Cell 90, 373-383.
28. Scharpfenecker, M., Fiedler, U., Reiss, Y. & Augustin, H.G. (2005) The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell Sci. 118, 771-780.
29. Schneider, P., MacKay, F., Steiner, V., et al. (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747-1756.
30. Sugita, S., Kohno, T., Yamamoto, K., Imaizumi, Y., Nakajima, H., Ishimaru, T. & Matsuyama, T. (2002) Induction of macro-phage-inflammatory protein-3alpha gene expression by TNF-dependent NF-κB activation. J. Immunol. 168, 5621-5628.
31. Thompson, J.S., Bixler, S.A., Qian, F., et al. (2001) BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293, 2108-2111.
32. Velazquez, L., Fellous, M., Stark, G.R. & Pellegrini, S. (1992) A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70, 313-322.
33. Wang, C.Y., Mayo, M.W. & Baldwin, A.S. (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787.
34. Xia, X.Z., Treanor, J., Senaldi, G., et al. (2000) TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J. Exp. Med. 192, 137-143.
35. Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S.T., Weil, R., Agou, F., Kirk, H.E., Kay, R.J. & Israel, A. (1998) Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93, 1231-1240.
36. Yan, M., Brady, J.R., Chan, B., Lee, W.P., Hsu, B., Harless, S., Cancro, M., Grewal, I.S. & Dixit, V.M. (2001) Identification of novel receptor for B lymphocytes stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11, 1547-1552.
37. Yang, J., Lin, Y., Guo, Z., Cheng, J., Huang, J., Deng, L., Liao, W., Chen, Z., Liu, Z. & Su, B. (2001) The essential role of MELL3 in TNF-induced NF-κB activation. Nat. Immunol. 2, 620-624.
38. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M. & Karin, M. (1997) The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation. Cell 91, 243-252.
39. Zhao, Q. & Lee, F.S. (1999) Mitogen-activated protein kinase/ ERK kinase kinase 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase β. J. Biol. Chem. 274, 8355-8358.